2-amino-4-hydroxy-5-pyrimidinecarboxa mide derivatives and related compounds as inhibitors of T cell activation for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2004258862 (hide)

International Classifications

Event Publications

5 January 2006 PCT application entered the National Phase

PCT publication WO2005/009443 Priority application(s): WO2005/009443

27 September 2007 Application Accepted

Published as AU-B-2004258862

24 January 2008 Standard Patent Sealed

21 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.